Search
for
Sort by
Research 241–270 of 1000+
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Title Choice of treatment for severe forms of alopecia areata (case reports)
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata
- Alopecia areata in children: an overview of clinical features and recent treatment options
- The changing landscape of managing hair loss: a 30‐year perspective
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Mechanisms of autophagy and their implications in dermatological disorders
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Treatment of pediatric alopecia areata: A systematic review
- Treating Alopecia Areata: Current Practices Versus New Directions
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Pathomechanisms of immune-mediated alopecia
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Current Treatments for Alopecia Areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Ruxolitinib found to cause eyelash growth: a case report
- Alopecia areata following COVID-19 vaccine: a systematic review